Paper Review Records
All Paper Review Records
15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
160
days
Precision neoadjuvant treatment with AI-assisted subtyping in HR+/HER2−breast cancer: A randomized, phase 2 trial FASCINATE-N
Authors
Jun-Jie Li; Lin-Xiaoxi Ma; Peng Ji; Li Chen; Jiong Wu; Guang-Yu Liu; Yi-Feng Hou; Gen-Hong Di; Zhen Hu; Yi-Zhou Jiang; Lei Fan; Zhong-Hua Wang; Ke-Da Yu; Zhi-Ming ShaoShow moreShow less
Affiliations
Department of Breast Surgery, Fudan University Shanghai Cancer Center, Key Laboratory of Breast Cancer in Shanghai, Shanghai 200032, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, ChinaShow moreShow less
323
days
Corpora amylacea profiling reveals disease stage and brain region-specific alterations in glycogen metabolism in Alzheimer’s disease patient brains
Authors
Jonathan A.B. Villareal; Tim Bathe; Ana de la Rosa; Rohan V. Sharma; Elvin O. Hernández Gómez; Alison M. Ryan; Tara R. Hawkinson; Anthony M. Tuzzolo; Eduardo Medina-Parrilla; Jennifer L. Phillips; Wangchen Tsering; Andrea A. Iturbe; Benoit I. Giasson; Ramon C. Sun; Matthew S. Gentry; Stefan ProkopShow moreShow less
Affiliations
Department of Pathology, Immunology & Laboratory Medicine, University of Florida, Gainesville, FL 32610, USA; Center for Translational Research in Neurodegenerative Disease, University of Florida, Gainesville, FL 32610, USA; Department of Neuroscience, University of Florida, Gainesville, FL 32610, USA; Norman Fixel Institute for Neurological Diseases, University of Florida, Gainesville, FL 32608, USA; McKnight Brain Institute, University of Florida, Gainesville, FL 32610, USA; Department of Biochemistry and Molecular Biology, University of Florida, Gainesville, FL 32610, USA; Center for Advanced Spatial Biomolecule Research, University of Florida, Gainesville, FL, USA; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, 81377 Munich, Germany; Graduate School of Systemic Neurosciences (GSN), Department Biology II Neurobiology, LMU Munich, 82152 Planegg-Martinsried, GermanyShow moreShow less
213
days
DNA methylation profiling enables subclassification of mucinous ovarian carcinoma and distinguishes it from extraovarian mucinous metastases
Authors
Teodor G. Calina; Elena Grafenhorst; Simon Schallenberg; Markus Möbs; Bjarne Daenekas; Alexandru A. Sabo; BaoQing Chen; Ines Koch; Tobias Janik; Michael Churchman; Charlie Gourley; Elizabeth L. Christie; Catalin Vasilescu; Vlad Herlea; Wolfgang D. Schmitt; Nicolae Leopold; Florian Heitz; Angelina Vlaski; Yuri Tolkach; Felix Bremmer; Frederick Klauschen; Reinhard Büttner; Philipp Ströbel; Eike Burandt; Guido Sauter; Frank L. Heppner; Eliane T. Taube; Jalid Sehouli; Ioana E. Braicu; Philipp Euskirchen; David Horst; Kylie L. Gorringe; David Capper; Mihnea P. DragomirShow moreShow less
Affiliations
Faculty of Physics, Babeş-Bolyai University, Cluj-Napoca, Romania; TGC Ventures UG, Berlin, Germany; Institute of Pathology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany; German Cancer Consortium (DKTK), Partner Site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Neuropathology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany; Department of Pediatric Cardiology, Pulmonology and Pediatric Intensive Care Medicine, University Children’s Hospital Tübingen, Tübingen, Germany; State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangdong Esophageal Cancer Institute, Guangzhou, China; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China; Nicola Murray Centre for Ovarian Cancer Research, CRUK Scotland Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, Scotland, UK; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Department of Surgery, Fundeni Clinical Institute, Bucharest, Romania; Department of Pathology, Fundeni Clinical Institute, Bucharest, Romania; Department of Gynecology and Gynecologic Oncology, Evangelische Kliniken Essen-Mitte, Essen, Germany; Institute of Pathology, Ludwig-Maximilians-Universität Munich, Munich, Germany; Institute of Pathology, University Hospital Cologne, Köln, Germany; Institute of Pathology, University Medical Center Göttingen, Göttingen, Germany; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany; Department of Gynaecology, European Competence Center for Ovarian Cancer, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany; North Eastern German Society for Gynecological Cancer, Tumor Bank Ovarian Cancer Network, Berlin, Germany; Berlin Institute of Health, Berlin, GermanyShow moreShow less
353
days
Combination of exosome vaccines, lenvatinib, and anti-PD-1 eradicates tumor in autochthonous hepatocellular carcinoma mice
Authors
Bingfeng Zuo; Xuening Liu; Zheng Zhang; Zhenqiang Xu; Yanzhi Zhong; Yang Zhang; Qian Yang; Zezhen Yu; Kangjie Zhao; Yali Zhang; Yiqi Seow; HaiFang YinShow moreShow less
Affiliations
State Key Laboratory of Experimental Hematology & the Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics & Division of Medical Technology & School of Basic Medical Sciences, Tianjin Medical University, Qixiangtai Road, Heping District, Tianjin 300070, China; Department of Urology, The Second Hospital of Tianjin Medical University, Tianjin Institute of Urology, Tianjin 300211, China; Genome Institute of Singapore (GIS), Agency for Science, Technology and Research (ASTAR), 60 Biopolis Street, Genome, Singapore 138672, Republic of SingaporeShow moreShow less
227
days
Nilotinib induces immunogenic cuproptosis to potentiate cancer immunotherapy
Authors
Lei Yao; Deze Zhao; Yu Meng; Yihuang Liu; Hui Su; Danyao Chen; Ziyu Guo; Daishi Li; Linfeng Li; Qian Zhou; Shengchao Xu; Furong Zeng; Xiang Chen; Ledu Zhou; Guangtong DengShow moreShow less
Affiliations
Department of Dermatology, Xiangya Hospital, Central South University, Changsha 410008, China; Department of Hepatic Surgery, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China; Department of Thoracic Surgery, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China; National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, Changsha 410008, China; Hunan Engineering Research Center of Skin Health and Disease, Central South University, Changsha 410008, China; Hunan Key Laboratory of Skin Cancer and Psoriasis, Central South University, Changsha 410008, China; National Clinical Research Center of Geriatric Disorders, Xiangya Hospital, Central South University, Changsha 410008, China; Hu Nan Key Laboratory of Aging Biology, Changsha 410008, China; Department of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan Province 410008, China; Department of Neurosurgery, Xiangya Hospital, Central South University, No.87, Xiangya Road, Changsha, Hunan 410008, ChinaShow moreShow less
411
days
A poly(I:C)/QS-21-based in situ vaccine synergizes with anti-PD-1 therapy to overcome tumor immunoresistance
Authors
Wenbo Zhang; Xinrui Ni; Luoyi Zhuo; Jiangrui Liu; Guang Yang; Jianming Li; Lingai Tang; Xiuli Du; Chun Shan; Guoqiang Feng; Wenguang Wang; Qi Gao; Qiang Sui; Min Xia; Chunwang Yuan; Dexiang Chen; Yong Yang; Duowei Wang; Xianjing LiShow moreShow less
Affiliations
School of Translational Research, China Pharmaceutical University, Nanjing 211198, China; Shanghai Anyikang Biotechnology Co., LTD, Shanghai 200131, China; Maxvax Biotechnology Co., LTD, Chengdu 610200, China; Center of Interventional Oncology and Liver Diseases, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China; Interventional Department of Liver Diseases and Tumors with Integrated Traditional Chinese and Western Medicine, The Second Hospital of Hohhot, Hohhot 010020, China; School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 211198, China; Center for New Drug Safety Evaluation and Research, China Pharmaceutical University, Nanjing 211198, ChinaShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review62 days
Median65 days